NCT03775265 2026-03-18
Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer
National Cancer Institute (NCI)
Phase 3 Active not recruiting
Clinical Trials
29 trialsNCT04164082 2026-03-18
Testing the Addition of an Anti-cancer Drug, Pembrolizumab, to the Usual Intravesical Chemotherapy Treatment (Gemcitabine) for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder Cancer
National Cancer Institute (NCI)
Phase 2 Active not recruiting
NCT07061964 2026-03-18
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
National Cancer Institute (NCI)
Phase 2 Recruiting
NCT06914479 2026-03-11
Virus-Based Gene Therapy (AdV-HSV1-TK and AdV-Flt3L) in Combination With Valacyclovir for the Treatment of Pediatric and Young Adult Patients With Resectable, Recurrent Primary Malignant Brain Tumors
University of Michigan Rogel Cancer Center
Phase 1 Recruiting
NCT07000084 2026-03-04
GAIN-BCG
Alliance for Clinical Trials in Oncology
Phase 3 Recruiting
NCT06805305 2026-02-23
DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)
Diakonos Oncology Corporation
Phase 2 Recruiting
NCT07288112 2026-02-23
DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma
Diakonos Oncology Corporation
Phase 1/2 Recruiting
NCT05521698 2026-02-17
Study to Determine Possible Effects of Apalutamide, Compared to Placebo, on EGFR Expression in Patients With Non-muscle Invasive Bladder Cancer
University of Wisconsin, Madison
Phase 1 Not yet recruiting
NCT04221503 2026-01-08
Niraparib/TTFields in GBM
Abramson Cancer Center at Penn Medicine
Phase 2 Active not recruiting
NCT02792582 2025-11-12
A Phase II Trial of Intensity-Modulated Proton Therapy for Incompletely Resected Craniopharyngioma and Observation for Craniopharyngioma After Radical Resection
St. Jude Children's Research Hospital
Phase 2 Active not recruiting
NCT06629233 2025-08-29
Tn-Miner
University Ghent
Phase NA Enrolling by invitation
NCT06537154 2025-07-30
NEO-BLAST
University of British Columbia
Phase 2/3 Recruiting
NCT07067749 2025-07-24
TEMPO-MIBC
University of Rome Tor Vergata
Phase 3 Recruiting
NCT02722512 2025-02-18
Trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine
Ann & Robert H Lurie Children's Hospital of Chicago
Phase 1 Terminated
NCT06820502 2025-02-11
OUTCOMES of SIMULTANEOUS TRANSURETHRAL PROSTATE and BLADDER TUMOR RESECTION VERSUS TRANSURETHRAL BLADDER TUMOR RESECTION in BLADDER TUMOR with BLADDER PROSTATE HYPERPLASIA
Allama Iqbal Medical College
Phase NA Active not recruiting
NCT03189420 2024-04-19
Glioma Microenvironment an Exploratory Study
Hospital Sirio-Libanes
Active not recruiting
NCT06324058 2024-03-21
Cryoablation Versus BCG Instillation Therapy for High-risk NMIBC
Huashan Hospital
Phase NA Not yet recruiting
NCT06151847 2024-02-28
Lifileucel With Reduced Dose Fludarabine/Cyclophosphamide Lymphodepletion and Interleukin-2 for the Treatment of Patients With Unresectable or Metastatic Melanoma
University of Kansas Medical Center
Phase 2 Unknown
NCT06146725 2023-11-27
RESBIOP
Erasmus Medical Center
Recruiting
NCT06146738 2023-11-27
PALSUR
Erasmus Medical Center
Recruiting
NCT05445648 2022-12-28
CBPTMI
First Affiliated Hospital Xi'an Jiaotong University
Phase 2 Unknown
NCT05123404 2021-11-17
Validation of VI-RADS for the Detection of Detrusor Muscle Invasion
Egyptian Biomedical Research Network
Phase NA Unknown
NCT02855086 2020-03-31
Cetuximab-IRDye 800CW in Detecting Tumors in Patients With Malignant Glioma Undergoing Surgery
Stanford University
Phase 1/2 Terminated
NCT02579980 2019-03-26
Quantitative Imaging Biomarkers for Sarcoma
Columbia University
Phase NA Completed
NCT02700724 2018-08-13
Observation Versus Immediate Surgery of Low Risk Bladder Cancer
Vanderbilt University Medical Center
Phase NA Terminated
NCT01900327 2018-05-11
NEOPA
Universitätsklinikum Hamburg-Eppendorf
Phase 3 Terminated
NCT00262951 2017-12-28
Chemoradiation in Locally Advanced Pancreatic Cancer
Masonic Cancer Center, University of Minnesota
Phase 2 Terminated
NCT00653250 2013-05-21
Celecoxib in Treating Patients With Stage I, Stage II, or Stage IIIA Non-Small Cell Lung Cancer
Vanderbilt-Ingram Cancer Center
Phase NA Completed
NCT00347256 2008-12-10
Chemoradiotherapy Followed by Surgery for Advanced Paranasal Sinus Cancer
University of Tennessee
Phase NA Withdrawn